Olink Proteomics

Olink operates in the biotechnology sector, specializing in proteomics, which is the large-scale study of proteins. The company provides highly sensitive and accurate protein quantification solutions, empowering scientists to investigate complex biological processes with precision. Olink's core product, Olink Explore HT, allows for the measurement of 5,400 proteins, facilitating the understanding of disease at the protein level. The company serves a diverse range of clients, including academic researchers, pharmaceutical companies, and healthcare institutions. By integrating proteomics with genomics, Olink aims to accelerate the discovery of novel drug targets and advance disease understanding and therapy development. The business model is primarily B2B (business-to-business), generating revenue through the sale of its proteomics solutions and related services. Olink's innovative technology supports population-scale studies and real-time biology, providing actionable insights into human health and disease.

Keywords: proteomics, protein quantification, drug development, biotechnology, genomics integration, disease research, academic researchers, pharmaceutical companies, healthcare institutions, B2B.